Bruno Roche,Didier Samuel
Bruno Roche
Liver transplantation is the only therapy for patients with end-stage liver disease, hepatocellular carcinoma, or fulminant hepatitis due to hepatitis D virus (HDV) and hepatitis B virus (HBV) coinfection or superinfection. Patients chronic...
Cihan Yurdaydin
Cihan Yurdaydin
Chronic delta hepatitis (CDH) remains the most progressive form of chronic viral hepatitis and as such its successful treatment is important. However, in striking contrast to the situation in chronic hepatitis B and C, no new drugs for its ...
Patrizia Farci,Grazia Anna Niro
Patrizia Farci
Hepatitis D is caused by infection with hepatitis D virus (HDV), a defective RNA virus that requires the obligatory helper function of hepatitis B virus (HBV) for its in vivo transmission. Thus, HDV is acquired only by coinfection with HBV ...
Antonella Olivero,Antonina Smedile
Antonella Olivero
The first step in the diagnosis of hepatitis delta virus (HDV) infection is testing HBsAg-positive individuals for the antibody to the HD antigen (anti-HD).In anti-HD-positive patients, the next step is testing for HDV RNA in serum to deter...
Mario Rizzetto,Alessia Ciancio
Mario Rizzetto
Hepatitis D occurs worldwide. The major victims of the hepatitis D virus (HDV) are individuals carrying the hepatitis B surface antigen (HBsAg); around 5% of the HBsAg carriers in the world are infected also by HDV. With the implementation ...
Ricardo Flores,Susana Ruiz-Ruiz,Pedro Serra
Ricardo Flores
There is a subviral world, whose most prominent representatives are viroids. Despite being solely composed by a circular, highly structured RNA of ~250 to 400 nucleotides without protein-coding ability (all viruses code for one or more prot...
John M Taylor
John M Taylor
Although much of the current understanding of the replication of hepatitis D virus (HDV) has been gained from ex vivo rather than in vivo studies, many seemingly unique aspects have been discovered. These include the ultra-small size and ci...
Hepatitis D(delta) [0.03%]
丁型肝炎病毒
Mario Rizzetto
Mario Rizzetto
Hepatocellular carcinoma in a noncirrhotic patient with HIV: a case report and review of the literature [0.03%]
一项人类免疫缺陷病毒感染肝细胞癌非肝硬化患者的病例报告和文献回顾
Neil Parikh,Valerie Martel-Laferriere,Xuchen Zhang et al.
Neil Parikh et al.
A 59-year-old man with human immunodeficiency virus (HIV) was referred for persistently elevated liver enzyme activities. His HIV was well controlled on antiretroviral therapy and his viral load was undetectable. He had no history of chroni...
Alyson N Fox,Parsia A Vagefi,Peter G Stock
Alyson N Fox
In the last three decades, the management of human immunodeficiency virus (HIV) has improved dramatically. The use of combination antiretroviral therapy (ART) has been successful at preventing death and the myriad infectious, malignant, and...